Bayer is to purchase Merck's complete Schering share package at 89 per share, the Leverkusen company announced. The two companies have agreed to the deal whereby Bayer is to pay 3 more per share than the 86 it had originally offered the Schering shareholders.
Merck, which is based in Darmstadt, confirmed that it intends to sell its stake of 21.8 percent of Schering to Bayer thus clearing the way for a take over. The value of the transaction will yield Merck a profit of 3.7 billion. Bayer shares jumped by almost 6.7 percent to 32.60 and Merck shares increased by 6.3 percent to 72.76. Schering's own shares rose by over 2 percent to 88.99.
The latest development heralds the end of an unusually aggressive takeover bid by German standards. Merck fired the opening shot when it made a move for a hostile takeover of Schering. Bayer then appeared as a white knight, coming to Schering's rescue by outbidding Merck. However, Merck would not accept defeat and over the last few days the company bought up a massive amount of Schering shares on the open market. Merck almost managed to reach a blocking interest of 25.1 percent.
Bayer was taken by surprise by the maneuver and only filed a lawsuit against Merck in the US on Tuesday. It now plans to withdraw the case, as part of the takeover deal.
The decision came after all three companies held joint talks about Merck's actions over the last few days. "We're very pleased about Merck's decision, because a lengthy competitive bidding process would have greatly affected Schering's future," said Bayer CEO Werner Wenning. The timing was tight for Bayer -- if Merck were still in the picture it would have to have controlled 75 percent of the shares by midnight Wednesday, in order to push through its planned takeover.
smd/spiegel/ap
Post to other social networks:
Stay informed with our free news services:
| All news from SPIEGEL International | Twitter | RSS |
© SPIEGEL ONLINE 2006
All Rights Reserved
Reproduction only allowed with the permission of SPIEGELnet GmbH